In the late 1970s, the humming fluorescent lights of the data center at the Meridian Institute were the only thing louder than Arthur’s thoughts. He sat hunched over an IBM 3277 Display Station
Arthur’s work that night would eventually lead to new therapeutic strategies to overcome drug resistance in breast cancer and other solid tumors. He left the data center as the sun began to rise, his 3277 terminal finally dark, leaving behind a legacy that would take decades for the rest of the medical world to fully decode. 3277 rar
He sat back, the green light reflecting in his glasses. He had found the molecular mechanism behind the resistance. It wasn't just about adding more retinoic acid; it was about silencing the hijackers. The Legacy In the late 1970s, the humming fluorescent lights
, his fingers hovering over the heavy beam-spring keys. On the screen, a flickering green cursor waited for a command that could change the course of oncology. He sat back, the green light reflecting in his glasses
Arthur pulled a stack of punch cards from his bag, each one representing a different patient profile. He had spent months coding the logic of transcriptional regulation into the mainframe. Retinoic acid was supposed to be the key. The Lock: The RAR-RXR complex, waiting in the nucleus. The Glitch: In solid tumors, the "lock" seemed to jam.
where Arthur faces the medical board with his findings?